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Abstract Two ubiquitously expressed protein tyrosine phospha-
tases, PTP-S2 and PTP-S4 (also known as TC45 and TC48,
respectively), are alternately spliced products of the same gene.
Overexpression of PTP-S2 by transient transfection induced
chromatin condensation and nuclear fragmentation, typical of
apoptosis. Expression of PTP-S4 resulted in a much lower
number of cells with apoptotic phenotype. PTP-S2 induced
apoptosis in MCF7 and A549 human tumor cell lines which are
p53 positive but not in HeLa and SW620 cells which are p53
negative. Apoptosis induced by PTP-S2 in MCF7 cells was
inhibited by cotransfection with mutant p53 (Arg-273CHis) but
not by wild type p53. PTP-S2 induced apoptosis was inhibited by
antiapoptotic protein Bcl2 and certain inhibitors of caspases.
These results suggest that the nuclear tyrosine phosphatase PTP-
S2 induces p53 dependent, serum starvation independent and
caspase mediated apoptosis.
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1. Introduction
Programmed cell death or apoptosis, as well as cell prolif-
eration, is required for the normal development and function
of multicellular organisms [1]. Protein tyrosine phosphoryla-
tion mediated by protein tyrosine kinases (PTKs) and protein
tyrosine phosphatases (PTPs) has been implicated in cell sur-
vival and cell death [2,3]. Speci¢c tyrosine kinases like c-abl
and AATYK have been implicated in apoptosis and the ty-
rosine kinase activity of some growth factor receptors is es-
sential for survival of cells [4^6]. Using PTP inhibitors it has
been shown that activity of PTPs is required for apoptosis to
take place but in these studies the role of individual enzymes
is not de¢ned [2]. Recently two tyrosine phosphatases have
been shown to be involved in the control of apoptosis. One
of these, termed FAP-1, associates with Fas receptor and
blocks Fas mediated apoptosis [7]. The other enzyme, LAR,
is a transmembrane protein that induces apoptosis upon over-
expression [8]. Dual speci¢city phosphatase Cdc25A is in-
volved in the induction of apoptosis by c-Myc overexpression
[9]. Another dual speci¢city phosphatase, MKP-1, is involved
in the protection of cells against apoptosis induced by UV
irradiation [10].
Four di¡erent forms of a non-receptor type PTP are gen-
erated by alternative splicing; two of these forms, PTP-S2 and
PTP-S4 (also known as TC45 and TC48, respectively), are ma-
jor forms which are expressed in rat as well as human cells
[11]. PTP-S2, which is a polypeptide of 382 amino acids, binds
to non-speci¢c DNA in vitro and localizes in the nucleus [12^
16]. The last six amino acids of PTP-S2 are replaced by 34
amino acids (mostly hydrophobic) in PTP-S4. PTP-S4 does
not bind to non-speci¢c DNA and shows perinuclear and
cytoplasmic localization [16]. A knock out mouse which
does not express PTP-S has been created and the homozygous
null animals are unable to survive beyond 3^5 weeks [17].
These mice exhibit speci¢c defects in bone marrow, B cell
lymphopoiesis and erythropoiesis and also impaired T and
B cell functions. In the knock out mice all the forms of
PTP-S were knocked out and, therefore, the observed e¡ects
cannot be attributed to any particular isoform.
The level of PTP-S mRNA is transiently increased in G1
phase upon mitogenic stimulation in a variety of cells, such as
T lymphocytes, HeLa cells, F111 ¢broblasts, liver cells, etc.
[15,18,19]. In most of these studies individual isoforms were
not analyzed. Recently it has been shown in our laboratory
that PTP-S2 as well as PTP-S4 mRNA levels increase several
fold in the G1 phase during rat liver regeneration [16]. Over-
expression of PTP-S2 in HeLa cells at moderate levels leads to
an increase in the rate of cell division, a loss of contact in-
hibition, an alteration in the cellular morphology and a re-
duction in the requirement of serum [20]. These observations
suggest that PTP-S2 has a role in the regulation of cell pro-
liferation.
Some of the proteins involved in regulating cell prolifera-
tion are also known to play a role in the induction or inhi-
bition of apoptosis, such as p53, pRb, c-Myc, Cdc25A, etc.
[21,22]. Therefore it is possible that PTP-S2 may have a role
in the induction or inhibition of apoptosis. Here we have
analyzed the e¡ect of overexpression of PTP-S2 on the induc-
tion of apoptosis in various cells as determined by chromatin
condensation and nuclear fragmentation. Our results suggest
that the nuclear isoform PTP-S2 but not PTP-S4 induces a
signi¢cant level of apoptosis.
2. Materials and methods
2.1. Cell culture and transfection
HeLa, Cos-1, MCF-7, SW620 and A549 cells were maintained and
grown in DMEM containing 10% fetal calf serum at 37‡C and 5%
CO2. For transfection, cells were plated on coverslips and transfected
with the expression plasmids using Lipofectamine as described earlier
[16]. Total concentration of DNA used was 1 Wg/ml in all experiments.
2.2. Expression plasmids
In order to express PTP-S2, PTP-S4 and vPTP-S4 in mammalian
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 7 3 4 - 6
*Corresponding author. Fax: (91) (40) 7171195.
E-mail: gshyam@ccmb.ap.nic.in
Abbreviations: PTP, protein tyrosine phosphatase; PTK, protein ty-
rosine kinase; GFP, green £uorescent protein
FEBS 22189 18-6-99
FEBS 22189FEBS Letters 453 (1999) 308^312
cells, these cDNAs cloned in pCB6 vector were used as described
earlier [16]. The murine Bcl2 gene in pMEP4 was provided by Dr.
Yusuf A. Hannun [23], and green £uorescent protein (GFP) plasmid
was from Clontech. Mutant p53 in which Arg-273 is replaced by His
has been described previously [24]. Poxvirus gene CrmA cloned in
pcDNA3 has been described previously [25]. In cotransfection experi-
ments, PTP-S2 along with either Bcl2 or CrmA plasmids was used.
Control vectors were used to maintain uniform DNA concentrations.
2.3. Immunostaining and quantitative analysis of apoptotic cells
After transfection, cells were ¢xed in 3.7% formaldehyde and per-
meabilized in 0.5% Triton X-100 and 0.05% Tween 20 as described
earlier [13,16]. After blocking in 2% BSA, cells were incubated with
monoclonal antibody (G11) that recognizes all the rat PTP-S isoforms
but not human or monkey PTP-S proteins [13,16]. This monoclonal
antibody recognizes an epitope in the C-terminal 40 amino acids of
PTP-S2 which is also present in PTP-S4 and vPTP-S4. Anti-mouse
FITC conjugated secondary antibodies were used to detect the cells
expressing exogenously transfected PTP-S proteins. Cells were
mounted in 90% glycerol with 1 mg/ml paraphenylenediamine and
0.5 Wg/ml DAPI to visualize nuclear morphology. Cells were observed
using an Olympus microscope. Cells showing FITC staining were
counted and those that showed condensed chromatin or fragmented
nuclei were scored as apoptotic. Cells not showing PTP-S expression
in the same coverslips were also scored for the number of apoptotic
cells. An average of 200 expressing cells and 1000 non-expressing cells
were counted in each coverslip. The data shown in various ¢gures
represent mean þ S.D. from at least three independent experiments.
Confocal microscopy was carried out using the Ultima Confocal sys-
tem from Meridian equipped with an inverted Olympus microscope
and an argon ion laser. Cells were analyzed by optical sectioning and
in order to get an overall view of apoptotic cells, optical sections were
combined.
2.4. Immunoblotting
Immunoblotting of transfected cells was carried out as described
previously using G11 monoclonal antibody [13,16]. Cos-1 cells tran-
siently transfected with plasmid vectors were harvested after 48 h of
transfection and suspended in SDS sample bu¡er for electrophoresis.
Cell lysates were fractionated by electrophoresis in 10% polyacryl-
amide gel in the presence of SDS. Proteins were then transferred to
nitrocellulose membrane electrophoretically. The membrane was
blocked for at least 1 h with 1% bovine serum albumin in 10 mM
Tris, pH 8.0, 150 mM NaCl, 0.05% Tween 20 and 0.2% gelatin. The
blot was then incubated with monoclonal antibody G11 (hybridoma
supernatant diluted 1:10) for 2 h. After washing, the blot was incu-
bated with alkaline phosphatase conjugated anti-mouse IgG for 1 h.
Immunoreactive bands were detected using nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate.
3. Results and discussion
In order to analyze the e¡ect of overexpression of PTP-S2
and PTP-S4 on the induction of apoptosis, Cos-1 cells were
transiently transfected with the plasmid vectors expressing
these proteins. After 24^72 h of transfection, cells were ¢xed
and stained for PTP-S and DNA. It was found that about
30% of PTP-S2 overexpressing cells showed apoptosis (after
48 h of transfection) as determined by nuclear fragmentation
and chromatin condensation (Figs. 1 and 2). Only about 3%
of cells that did not express PTP-S2 in the same coverslips
showed apoptosis. Cell death can occur by either apoptosis or
necrosis which are biochemically and morphologically distinct
processes. At the morphological level apoptosis is character-
ized by chromatin condensation and margination along the
inner nuclear membrane, cytoplasmic condensation and mem-
brane blebbing without disintegration of the cellular mem-
brane. At a later stage the cell disintegrates into apoptotic
bodies. During necrotic cell death these nuclear and other
changes do not occur and instead, cytoplasmic swelling, lysis
of cell membrane takes place. In this study, for the purpose of
quantitation we have used direct visual quantitation of apop-
totic nuclei which is considered to be one of the most accurate
measures of apoptosis [25^27]. Non-apoptotic PTP-S2 ex-
pressing cells showed staining only in the nucleus but in apop-
totic cells PTP-S2 was distributed throughout the cell (Fig. 2).
About 10% of the PTP-S4 expressing cells showed apopto-
sis (Figs. 1 and 2). Cells transfected with control plasmid
showed apoptosis in about 3% of the cells. As an additional
control e¡ect of overexpression of GFP was determined and it
was found to induce apoptosis only in about 3^4% of express-
ing cells. The di¡erence in the induction of apoptosis by PTP-
S2 and PTP-S4 is not due to the levels of expression since
immuno£uorescence staining and immunoblot analysis (Fig.
1B) showed that PTP-S2 and PTP-S4 are expressed at nearly
the same level. Time course of PTP-S2 and PTP-S4 induced
apoptosis at 24, 48 and 72 h of transfection showed that PTP-
S2 induced apoptosis was highest at 48 h and lower at 24 or
72 h (data not shown). PTP-S4 induced apoptosis was same at
about 10% after 24 or 48 h of transfection and decreased
thereafter.
PTP-S2 and PTP-S4 di¡er in many properties including
subcellular location, interaction with non-speci¢c DNA, sub-
strate speci¢city, etc. These di¡erences are largely due to the
presence of a hydrophobic tail of 34 amino acids in PTP-S4
[16]. Therefore the e¡ect of deletion of C-terminal 34 amino
acids of PTP-S4 on the induction of apoptosis was analyzed.
Fig. 1. A: Quantitative representation of cell death induced by
PTP-S2, PTP-S4 and vPTP-S4. Cos-1 cells were transiently trans-
fected with the indicated constructs and stained for PTP-S expres-
sion and DNA after 48 h. The data represent mean þ S.D. of per-
centage of FITC stained cells with apoptotic phenotype relative to
the total number of FITC stained cells from at least three independ-
ent experiments. B: Western blot showing expression of PTP-S2,
PTP-S4 and vPTP-S4 in transiently transfected Cos-1 cells and Coo-
massie blue stained gel of the same samples. C: Schematic presenta-
tion of PTP-S2, PTP-S4 and vPTP-S4. Numbers indicate amino
acid position.
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Overexpression of this truncated protein vPTP-S4 (which
showed nuclear localization like PTP-S2) resulted in apoptosis
in about 28% of expressing cells (Figs. 1A and 2).
To investigate whether PTP-S2 induced apoptosis in a cell
type speci¢c manner, four other cell lines, HeLa, MCF7,
SW620 and A549, were used in similar transient transfection
assays. It was found that PTP-S2 induced apoptosis in MCF7
(human breast tumor) and A549 (lung carcinoma) cell lines in
about 30% of expressing cells after 48 h of transfection but
not in HeLa (cervical tumor) and SW620 (colon carcinoma)
cells (Figs. 3 and 4). MCF-7 and A549 are p53 positive cell
lines whereas HeLa and SW620 are p53 negative [28,29]. PTP-
S4 induced very little apoptosis in MCF-7 and A549 cells
(Fig. 3). vPTP-S4 induced apoptosis in MCF-7 and A549 cells
but not in HeLa cells (Fig. 3).
Since PTP-S2 did not induce apoptosis in p53 negative hu-
man tumor cell lines, it was possible that PTP-S2 induced
apoptosis may require a functional p53 protein. Therefore
we tested this possibility by cotransfecting PTP-S2 with a
mutant p53 which had His in place of Arg-273. Expression
of mutant p53 inhibited PTP-S2 induced apoptosis in MCF-7
cells whereas wild type p53 had no signi¢cant e¡ect (Fig. 5).
Since mutant p53 carried a mutation in the region of p53
involved in sequence speci¢c DNA binding, it seems likely
that PTP-S2 induced apoptosis requires the transcriptional
activation function of p53 which is dependent on sequence
speci¢c DNA binding. The role of p53 in the induction of
apoptosis is quite complex and cell type dependent [30,31].
In some cells transactivation function of p53 which is depend-
ent on sequence speci¢c DNA binding is required for induc-
tion of apoptosis, whereas in others it is not required [30,31].
In Cos-1 cells which are SV40 transformed, the large T anti-
gen would bind to p53 and functionally inactivate it. There-
fore it is likely that in Cos-1 cells PTP-S2 induced apoptosis
does not require functional p53. However, from the data on
Cos-1 cells it is not possible to draw a conclusion about the
role of p53 in PTP-S2 induced apoptosis, since SV-40 large T
antigen is known to induce apoptosis or cause a decrease in
apoptosis depending on the system used [32^35].
Expression of Bcl2 has been shown to inhibit cell death
triggered by diverse pathways [36]. We therefore performed
transient transfection of PTP-S2 in the presence or absence of
Bcl2 expression plasmid and found that cotransfection with
Bcl2 reduced the number of apoptotic cells with PTP-S2 ex-
pression in a dose dependent manner (Table 1). No di¡erence
Fig. 2. Nuclear fragmentation and chromatin condensation induced
by overexpression of PTP-S2. Cos-1 cells were transfected with indi-
cated PTP-S plasmid, stained for PTP-S expression with a mono-
clonal antibody and for DNA with DAPI. Cells were visualized
using a confocal microscope. Arrows indicate cells showing apoptosis.
Fig. 3. Induction of apoptosis in human tumor cell lines by PTP-S2
and PTP-S4. MCF-7, A549, HeLa and SW620 cells were transfected
with indicated plasmids and PTP-S expressing cells with apoptotic
morphology were quantitated.
Table 1
Inhibition of PTP-S2 induced apoptosis by Bcl2 and Crm A
Expression plasmid % apoptosis in expressing cells % apoptosis in non-expressing cells
1. PTP-S2: Bcl2 1:0 32.9 þ 1.7 (n = 6) 3.5
1:1 20.3 þ 6.5 (n = 6) 3.7
1:2 10.2 þ 2.9 (n = 6) 3.3
2. PTP-S2: Crm A 1:0 29.5 þ 1.3 (n = 5) 2.4
1:1 20.5 þ 2.8 (n = 5) 2.5
1:2 12.8 þ 1.0 (n = 6) 2.6
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was observed in the number of expressing cells or level of
PTP-S2 expression in the presence of Bcl2 plasmid.
Overexpression of certain genes involved in cell prolifera-
tion induces apoptosis only when cells are grown in medium
lacking growth factors [21]. In our experiments cells were fed
with serum containing medium 6 h after transfection and
maintained in 10% serum for the rest of the experiment.
Therefore serum starvation is not required for PTP-S2 in-
duced apoptosis. When the cells were kept in medium con-
taining 0.5% serum up to 48 h after transfection there was
some reduction in the percentage of apoptotic cells in low
serum (data not shown).
Poxvirus gene product Crm A is a potent inhibitor of cer-
tain caspases in vitro [37]. When a plasmid encoding Crm A
was cotransfected with PTP-S2, there was inhibition of PTP-
S2 induced apoptosis in a dose dependent manner (Table 1).
This suggests that caspase activity is required for PTP-S2
induced apoptosis. It was also found that addition of the
tetrapeptide Z-YVAD-cmk, a potent inhibitor of caspase 1,
inhibited PTP-S2 induced apoptosis whereas Z-DEVD-cmk, a
caspase 3 inhibitor, showed much less e¡ect (data not shown).
These results raise the possibility of involvement of caspase 1
in PTP-S2 induced apoptosis. Caspase 1 has been implicated
in apoptosis induced by various treatments [38^40]. Caspase 3
is not required for PTP-S2 induced apoptosis since it could
induce apoptosis in MCF-7 cells (Figs. 3 and 4) which lack
active caspase 3 due to a deletion in the gene [41].
The results presented here show that the nuclear tyrosine
phosphatase PTP-S2 upon overexpression induces apoptosis
as observed by morphological changes such as chromatin con-
densation, nuclear fragmentation and formation of apoptotic
bodies which are characteristic features of cells undergoing
apoptosis. The extent of apoptosis seen upon transient trans-
fection of PTP-S2 in Cos-1 cells is comparable to that induced
under similar conditions by other signalling molecules such as
LAR and MEKK1 [8,42]. Bcl2 prevents many, but not all
forms of cell death [36]. Cotransfection with Bcl2 reduced
the number of PTP-S2 overexpressing apoptotic cells indicat-
ing that PTP-S2 triggers a pathway directly connected to the
cell death machinery. This is supported by the observation
that cowpox virus protein CrmA and the peptide YVAD-
cmk inhibit PTP-S2 induced apoptosis.
Earlier, we have shown that stable cell lines derived from
HeLa cells overexpressing PTP-S2 have a growth advantage
over control cells [20]. In these clones, the level of PTP-S2
expression was very moderate compared to levels of overex-
pression achieved in transient transfection assays. Several pro-
teins like Cdc25A, c-Myc, p53 and E1A regulate pathways
leading to both cell proliferation and apoptosis [9,21]. Some
Fig. 4. E¡ect of overexpression of PTP-S2 in human tumor cell lines. Representative immuno£uorescence photomicrographs of cells transfected
with PTP-S2 plasmid are shown. After 48 h, transfected cells were detected by staining for PTP-S2 expression (FITC) and apoptotic cells by
DAPI staining. In the bottom row, phase contrast pictures show morphology of the stained cells.
Fig. 5. Inhibition of PTP-S2 induced apoptosis by mutant p53.
MCF-7 cells were cotransfected with PTP-S2 and mutant p53 or
normal p53 expression plasmids keeping the plasmid concentration
constant by using control plasmid. After 48 h of transfection, cells
were processed for immunostaining and percentage of apoptotic
cells was determined in the PTP-S2 expressing and non-expressing
cells.
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of these proteins like c-Myc and Cdc25A induce apoptosis
only under conditions of growth factor deprivation. But our
experiments showed that PTP-S2 can activate apoptotic path-
ways even in 10% serum supplemented medium. These results
suggest that PTP-S2 induced apoptosis does not take place
due to a con£ict created by signals to enhance cell prolifera-
tion. Maintenance of appropriate levels of this ubiquitously
expressed nuclear enzyme appears to be essential, as deregu-
lated expression disrupts cellular homeostasis leading to cell
death. Overexpression of this phosphatase at high level may
result in dephosphorylation of those proteins which play a
critical role in cell survival, leading to activation of a caspase
mediated pathway of cell death. Activation of this apoptotic
pathway requires sequence speci¢c DNA binding function of
p53 protein. To our knowledge this work is the ¢rst example
of involvement of a protein tyrosine phosphatase in the in-
duction of p53 dependent apoptosis.
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